As we laid out for you, as Dr. Gutierrez laid out for you, we’re going to file the IND for the first HOT product candidate in lung this month within the next several weeks, and then get in the clinic by the end of the year, if all goes well.
He said "this month" in the QA session at the end. You can find the transcript on Yahoo finance. I also like how the analyst asked if they had learned anything from NEO already being partnered over 2 years and yet still the first patient not dosed, and how not to take so long. His only answer was they hired the CMO. Lame.